Stocklytics Platform
Asset logo for symbol BMEA
Biomea Fusion
BMEA56
$3.89arrow_drop_down5.58%-$0.22
Penny Stock
Asset logo for symbol BMEA
BMEA56

$3.89

arrow_drop_down5.58%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Biomea Fusion (BMEA) Stocklytics Forecast

Biomea Fusion, Inc. (BMEA) is a biopharmaceutical company that specializes in the development of novel therapies in the field of oncology. With a dedicated team of scientists and experts, the company is focused on discovering and developing innovative treatments for patients with unmet medical needs. As a leader in the field of precision medicine, Biomea Fusion aims to revolutionize cancer therapy by targeting specific molecular abnormalities that drive the growth and progression of tumors.
Looking ahead, the stock price of Biomea Fusion, Inc. (BMEA) is subject to various predictions and forecasts. Analysts and AI-powered algorithms have been assessing the potential trajectory of the stock, taking into account numerous factors such as clinical trial results, market competition, and regulatory approvals. While it is important to note that stock predictions are inherently uncertain, industry experts have suggested that Biomea Fusion may experience significant growth in the coming years.
add Biomea Fusion to watchlist

Keep an eye on Biomea Fusion

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Biomea Fusion (BMEA) stock?

Analysts have set a target price of $46.3 for Biomea Fusion (BMEA), based on forecasts from 27 analysts. The predicted price range extends from a high of $90 to a low of $28. This represents a potential increase of up to 2.21K% and a decrease of 618.87% from the current price of $3.9. These forecasts are as of 2023 Mar 28.
help

What are the analyst ratings for Biomea Fusion (BMEA) stock?

Currently, there are no analyst ratings available for Biomea Fusion (BMEA), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Biomea Fusion (BMEA) stock?

At present, there is no AI or machine-learning-based price prediction available for Biomea Fusion (BMEA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level